Standardization and Quantification in FDG-PET/CT Imaging for Staging and Restaging of Malignant Disease - 28/03/14
, Francisco Pino-Sorroche, PhD bResumen |
There is a growing interest in using quantification in FDG-PET/CT in oncology, especially for evaluating response to therapy. Complex full quantitative procedures with blood sampling and dynamic scanning have been clinically replaced by the use of standardized uptake value measurements that provide an index of regional tracer uptake normalized to the administered dose of FDG. Some approaches have been proposed for assessing quantitative metabolic response, such as EORTC and PERCIST criteria in solid tumors. When using standardized uptake value in clinical routine and multicenter trials, standardization of protocols and quality control procedures of instrumentation is required.
El texto completo de este artículo está disponible en PDF.Keywords : PET/CT, FDG, Cancer, Quantification, Standardization, SUV, Quality control
Esquema
| The authors have nothing to disclose. |
Vol 9 - N° 2
P. 117-127 - avril 2014 Regresar al número
Artículo precedente
- FDG PET/CT: Normal Variations and Benign Findings - Translation to PET/MRI
- Mohsen Beheshti, Chun K. Kim
- Brain : Normal Variations and Benign Findings in Fluorodeoxyglucose-PET/Computed Tomography Imaging
- Valentina Berti, Lisa Mosconi, Alberto Pupi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?